The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies
Abstract
Background: Fluoroquinolone resistance is an issue of concern amongst physicians worldwide. In urology, fluoroquinolones are often used in the treatment of acute pyelonephritis and prostatitis, as well as infections caused by multidrug‐resistant pathogens. Aims: We aim to highlight the importance of antimicrobial stewardship and the need for ongoing biomedical research to discover novel agents in our losing battle against resistant pathogens. Materials and methods: In this review, we survey the literature and summarise fluoroquinolone resistance as it pertains to pyelonephritis and prostatitis, as well as alternative treatment strategies and prevention of multidrug resistance. Results: The rise of fluoroquinolone resistance in bacteria has reduced the available treatment options, often necessitating hospital admission for intravenous antibiotics, which places an additional burden on both patients and the healthcare system. Many countries such as Australia have attempted to limit fluoroquinolone resistance by imposing strict prescribing criteria, though these efforts have not been entirely successful. Solutions to overcome resistance include prevention, combination therapy and the development of novel antimicrobial agents. Conclusions: Prevention of the proliferation of resistant organisms by antimicrobial stewardship is paramount, and urologists are obliged to be aware of responsible prescribing practices such as referring to local guidelines when prescribing. By reserving fluoroquinolones for infections in which they are truly indicated and by prescribing based on both patient and local environmental factors, we can preserve this effective resource for future use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Underdosing and overuse have been identified as key factors accelerating this process.”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [241]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial Resistance: Implications and Costs
Dadgostar, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s234610 · Cited by 2,024
Research works printed but not linked: 46
- Hooper DC, 1987, Mechanisms of action of and resistance to ciprofloxacin, Am J Med, 82, 12
- 10.1093/jac/dki169 · DOI
- Pourahmad Jaktaji R, 2013, Study the expression of marA gene in ciprofloxacin and tetracycline resistant mutants of Escherichia coli, Iran J Pharm Res, 12, 923
- 10.1099/jmm.0.000873 · DOI · Paper page
- 10.1016/j.tim.2018.06.007 · DOI · Paper page
- 10.1093/jac/49.1.55 · doi:10.1093/jac/49.1.55
- Turnidge JD, 2013, Australian group on antimicrobial resistance community‐onset gram‐negative surveillance program annual report, 2010, Commun Dis Intell Q Rep, 37, E219, 10.33321/cdi.2013.37.33 · doi:10.33321/cdi.2013.37.33
- 10.1086/519268 · DOI · Paper page
- 10.3201/eid2209.160148 · DOI
- 10.1128/AAC.43.11.2736 · DOI · Paper page
- Kim J‐H, 2006, Quinolone resistance in community‐acquired acute pyelonephritis. Korean, J Nephrol, 571
- 10.1128/JCM.02594-14 · DOI
- 10.1592/phco.2005.25.10.1353 · DOI · Paper page
- 10.1016/j.juro.2010.11.088 · DOI · Paper page
- 10.1016/j.urology.2011.04.064 · doi:10.1016/j.urology.2011.04.064
- 10.1016/j.ijantimicag.2007.07.041 · doi:10.1016/j.ijantimicag.2007.07.041
- 10.1051/vetres:2001124 · DOI
- 10.1093/jac/dkq236 · DOI
- Bonkat G, 2018, Urological infections
- 10.1016/j.medmal.2014.02.003 · doi:10.1016/j.medmal.2014.02.003
- 10.3109/00365548.2011.572907 · DOI
- 10.1159/000444763 · DOI
- 10.1111/iju.12207 · doi:10.1111/iju.12207
- Park MG, 2019, Comparison of antibiotic susceptibility of Escherichia coli between community‐acquired and post‐prostate biopsy acute bacterial prostatitis, Arch Esp Urol, 72, 1018
- 10.1086/342955 · doi:10.1086/342955
- 10.1128/JCM.43.6.2962-2964.2005 · DOI
- 10.1086/323810 · doi:10.1086/323810
- 10.3343/alm.2014.34.4.286 · doi:10.3343/alm.2014.34.4.286
- 10.1016/S1473-3099(10)70027-X · DOI · Paper page
- 10.1592/phco.29.6.736 · doi:10.1592/phco.29.6.736
- 10.1186/s12957-019-1573-0 · DOI · Paper page
- 10.1111/bju.13402 · DOI
- Herness J, 2020, Acute pyelonephritis in adults: rapid evidence review, Am Fam Physician, 102, 173
- 10.1159/000049840 · DOI · Paper page
- 10.1007/s10156-007-0570-3 · doi:10.1007/s10156-007-0570-3
- 10.1093/jac/dkz015 · DOI
- 10.1128/AAC.01763-16 · doi:10.1128/aac.01763-16
- 10.1128/AAC.01011-16 · DOI
- 10.1128/AAC.01150-18 · doi:10.1128/aac.01150-18
- 10.1128/CMR.00031-19 · DOI · Paper page
- 10.1128/AAC.48.1.93-99.2004 · doi:10.1128/aac.48.1.93-99.2004
- 10.1086/652861 · doi:10.1086/652861
- 10.1097/00005392-199502000-00076 · doi:10.1097/00005392-199502000-00076
- 10.1016/S1569-9056(14)60562-5 · doi:10.1016/s1569-9056(14)60562-5
- 10.1111/j.1574-695X.2010.00723.x · DOI
- AURA, 2021, health
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Thompson, D., Xu, J., Ischia, J., & Bolton, D.
- Affiliations
- Department of Surgery The University of Melbourne, Austin Health Heidelberg Victoria Australia
- Venue
- BJUI Compass
- Publisher
- Wiley
- Published
- 2023-08-31
- Volume
- 5
- Issue
- 1
- Pages
- 5-11
- ISSN
- 2688-4526
- Cited by
- 37
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies. https://app.cochat.ai/papers/10.1002/bco2.286
- The paper
- Thompson, D., Xu, J., Ischia, J., & Bolton, D. (2024). Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies. BJUI Compass. https://doi.org/10.1002/bco2.286
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.